Crown Electrokinetics Corp. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss Per Share Attributable to Common Stockholders (Tables)

Net Loss Per Share Attributable to Common Stockholders (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of reconciliation of the net loss and the number of shares

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts):


	Year Ended December 31, 2024		Year Ended December 31, 2023
Numerator
Net loss	$	(25,946)	$	(28,984)
Less: Deemed dividend on Series D preferred stock	—		(6)
Less: Cumulative dividends on Series A preferred stock	(18)		(19)
Less: Cumulative dividends on Series B preferred stock	(17)		(107)
Less: Cumulative dividends on Series C preferred stock	(46)		(30)
Less: Cumulative dividends on Series D preferred stock	—		(53)
Less: Cumulative dividends on Series F preferred stock	(341)		(272)
Less: Cumulative dividends on Series F-1 preferred stock	(60)		(110)
Less: Cumulative dividends on Series F-2 preferred stock	(19)		(79)
Less: Deemed dividend in connection with conversion of Series A, Series B, and Series C preferred stock	(2,147)		—
Less: Deemed dividend in connection with conversion of Series F, Series F-1, and Series F-2	(3,874)		—
Net loss attributable to common stockholders, basic and diluted	$	(32,468)	$	(29,660)

Denominator
Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders	59,220		272
Less: weighted-average shares subject to repurchase	—		—
Basic and diluted net loss per share attributable to common stockholders	59,220		272

Net loss and attributable to common stockholders, basic and diluted
Basic and diluted net loss per share attributable to common stockholders	$	(548.26)	$	(109,044.12)

Schedule of antidilutive securities excluded from computation of earnings per share

The following table shows the outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders, on a common stock equivalent basis:


	December 31,
	2024	2023

Series A preferred stock	—	1
Series B preferred stock	—	2
Series C preferred stock	—	1
Series D preferred stock	—	—
Series F preferred stock	—	23
Series F-1 preferred stock	—	4
Series F-2 preferred stock	—	6
Warrants to purchase common stock (excluding penny warrants)	6,554	191
Warrants to purchase Series E preferred stock	34	34
Options to purchase common stock	102	92
Unvested restricted stock units	7,425	84
Commitment shares	-	9
	14,115	447